Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting treatment of bladder cancer using PTK7 aptamer-gemcitabine conjugate
Wei Xiang, Yongbo Peng, Hongliang Zeng, et al.
Biomaterials Research (2022) Vol. 26, Iss. 1
Open Access | Times Cited: 15

Showing 15 citing articles:

Recent advances in aptamer-based therapeutic strategies for targeting cancer stem cells
Biao Liu, Jiahao Liu, Xing Hu, et al.
Materials Today Bio (2023) Vol. 19, pp. 100605-100605
Open Access | Times Cited: 18
Effective therapy of advanced breast cancer through synergistic anticancer by paclitaxel and P-glycoprotein inhibitor
Sifeng Zhu, Chao Sun, Zimin Cai, et al.
Materials Today Bio (2024) Vol. 26, pp. 101029-101029
Open Access | Times Cited: 6
Double‐Layered Hollow Mesoporous Cuprous Oxide Nanoparticles for Double Drug Sequential Therapy of Tumors
Zongheng Li, Jing Yang, Bin Ren, et al.
Advanced Materials (2024) Vol. 36, Iss. 28
Closed Access | Times Cited: 6
Recent Advances in Aptamer-Based Sensors for Sensitive Detection of Neurotransmitters
Joon-Ha Park, Yun-Sik Eom, Tae‐Hyung Kim
Biosensors (2023) Vol. 13, Iss. 4, pp. 413-413
Open Access | Times Cited: 8
PTK7: an underestimated contributor to human cancer
Zhipeng Jin, Tianyu Guo, Xue Zhang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
An Aptamer That Rapidly Internalizes into Cancer Cells Utilizes the Transferrin Receptor Pathway
Xirui Song, Haixiang Yu, Cynthia Sullenger, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2301-2301
Open Access | Times Cited: 5
Design of chimeric GLP-1A using oligomeric bile acids to utilize transporter-mediated endocytosis for oral delivery
Seho Kweon, Jun-Hyuck Lee, Seong-Bin Yang, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 4
CD44 in Bladder Cancer
Jason E. Duex, Dan Theodorescu
Cancers (2024) Vol. 16, Iss. 6, pp. 1195-1195
Open Access | Times Cited: 1
Relationship between clonal evolution and drug resistance in bladder cancer: A genomic research review
Zhouting Tuo, Ying Zhang, Dengxiong Li, et al.
Pharmacological Research (2024) Vol. 206, pp. 107302-107302
Open Access | Times Cited: 1
Role of repeat transurethral resection in no-muscle-invasive bladder tumour: an umbrella review
Qingxin Yu, Ruicheng Wu, Zhouting Tuo, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 1
Therapeutic targeting of the protein tyrosine kinase-7 in cancer: an overview
Kim Mottard, Julie Cokaiko, Bernard Rogister, et al.
The Oncologist (2024)
Open Access
Preclinical Evaluation of PTK7-Targeted Radionuclide Therapy
Kim Lindland, Sara Westrøm, Srdjan Dragovic, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
USP8‐mediated PTK7 promotes PIK3CB‐related pathway to accelerate the malignant progression of non‐small cell lung cancer
Wencui Kong, Xuegang Feng, Zongyang Yu, et al.
Thoracic Cancer (2024)
Open Access
Targeting PD‐L1 with DNA Aptamers and Conjugated with Gemcitabine as a Novel Therapeutic Strategy for Bladder Cancer Chemotherapy Combined with Immunotherapy
Xing Hu, Hongliang Zeng, Yongbo Peng, et al.
Small Science (2023) Vol. 3, Iss. 12
Open Access | Times Cited: 1
Application and Immunogenicity of Aptamers in Cancer Therapy
Arin Ghasparian, Raha Amazadeh, Mahyar Ziyamolki, et al.
Biomedical Research Bulletin (2023) Vol. 1, Iss. 2, pp. 66-76
Open Access
Page 1

Scroll to top